5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine

C120H100F3N31O14S — CID 161499100

About 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine

5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine (PubChem CID 161499100) has the molecular formula C120H100F3N31O14S and a molecular weight of 2289.38 g/mol. Its IUPAC name is 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine.

Molecular Properties

• Compound Name: 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine
• PubChem CID: 161499100
• Molecular Formula: C120H100F3N31O14S
• Molecular Weight: 2289.38 g/mol
• Exact Mass: 2287.77
• IUPAC Name: 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine
• SMILES: Cc1cccc(Nc2nnc(-c3cccc(Oc4cc(N)nc(C)n4)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4cc(N)nc(N)n4)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccnc(N)c4)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccncc4)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccncc4C(F)(F)F)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccncc4S(N)(=O)=O)c3)o2)c1
• InChI: InChI=1S/C21H15F3N4O2.C20H18N6O2.C20H17N5O4S.C20H17N5O2.C20H16N4O2.C19H17N7O2/c1-13-4-2-6-15(10-13)26-20-28-27-19(30-20)14-5-3-7-16(11-14)29-18-8-9-25-12-17(18)21(22,23)24;1-12-5-3-7-15(9-12)24-20-26-25-19(28-20)14-6-4-8-16(10-14)27-18-11-17(21)22-13(2)23-18;1-13-4-2-6-15(10-13)23-20-25-24-19(29-20)14-5-3-7-16(11-14)28-17-8-9-22-12-18(17)30(21,26)27;1-13-4-2-6-15(10-13)23-20-25-24-19(27-20)14-5-3-7-16(11-14)26-17-8-9-22-18(21)12-17;1-14-4-2-6-16(12-14)22-20-24-23-19(26-20)15-5-3-7-18(13-15)25-17-8-10-21-11-9-17;1-11-4-2-6-13(8-11)22-19-26-25-17(28-19)12-5-3-7-14(9-12)27-16-10-15(20)23-18(21)24-16/h2-12H,1H3,(H,26,28);3-11H,1-2H3,(H,24,26)(H2,21,22,23);2-12H,1H3,(H,23,25)(H2,21,26,27);2-12H,1H3,(H2,21,22)(H,23,25);2-13H,1H3,(H,22,24);2-10H,1H3,(H,22,26)(H4,20,21,23,24)
• InChIKey: WGPGUXPOEBJUKI-UHFFFAOYSA-N
• XLogP: 26.95
• TPSA: 628.44 Ų
• H-Bond Donors: 11
• H-Bond Acceptors: 44
• Rotatable Bonds: 31
• Heavy Atoms: 169
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2289.38
LogP ≤ 5	26.95
H-Bond Donors ≤ 5	11
H-Bond Acceptors ≤ 10	44

Frequently Asked Questions

What is the IUPAC name of 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine?

The IUPAC name of 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine (CID 161499100) is 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine.

What is the SMILES notation for 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine?

The canonical SMILES for 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine is Cc1cccc(Nc2nnc(-c3cccc(Oc4cc(N)nc(C)n4)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4cc(N)nc(N)n4)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccnc(N)c4)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccncc4)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccncc4C(F)(F)F)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccncc4S(N)(=O)=O)c3)o2)c1.

What is the InChIKey of 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine?

The InChIKey is WGPGUXPOEBJUKI-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H15F3N4O2.C20H18N6O2.C20H17N5O4S.C20H17N5O2.C20H16N4O2.C19H17N7O2/c1-13-4-2-6-15(10-13)26-20-28-27-19(30-20)14-5-3-7-16(11-14)29-18-8-9-25-12-17(18)21(22,23)24;1-12-5-3-7-15(9-12)24-20-26-25-19(28-20)14-6-4-8-16(10-14)27-18-11-17(21)22-13(2)23-18;1-13-4-2-6-15(10-13)23-20-25-24-19(29-20)14-5-3-7-16(11-14)28-17-8-9-22-12-18(17)30(21,26)27;1-13-4-2-6-15(10-13)23-20-25-24-19(27-20)14-5-3-7-16(11-14)26-17-8-9-22-18(21)12-17;1-14-4-2-6-16(12-14)22-20-24-23-19(26-20)15-5-3-7-18(13-15)25-17-8-10-21-11-9-17;1-11-4-2-6-13(8-11)22-19-26-25-17(28-19)12-5-3-7-14(9-12)27-16-10-15(20)23-18(21)24-16/h2-12H,1H3,(H,26,28);3-11H,1-2H3,(H,24,26)(H2,21,22,23);2-12H,1H3,(H,23,25)(H2,21,26,27);2-12H,1H3,(H2,21,22)(H,23,25);2-13H,1H3,(H,22,24);2-10H,1H3,(H,22,26)(H4,20,21,23,24).

What are the key properties of 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine?

5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine has a molecular weight of 2289.38 g/mol, XLogP of 26.95, 31 rotatable bonds, 11 hydrogen bond donors, and 44 hydrogen bond acceptors.

Where does this data come from?

All data for 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine is sourced from PubChem (CID 161499100), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).